Hong Kong Health Unit Panned For Poor Oversight Of Western Drugs
This article was originally published in PharmAsia News
Executive Summary
Hong Kong health authorities are being criticized by a legislative watchdog for failing to ensure the safety, efficacy and quality of Western drugs